The Axinon NMR system. Image courtesy of Numares.

Axinon aims to identify early kidney rejection in post-transplant surveillance, assess kidney function by improved determination of glomerular filtration rate, and ascertain risk for cardiovascular disease. If cleared, Axinon would become the first NMR-based clinical laboratory system to use AI-evaluated metabolic data, according to Numares.